The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Size Of The Insomnia Therapeutics Market In 2026 And How Much Will It Reach By 2030?
The insomnia therapeutics market size has experienced strong growth in recent years. It is projected to expand from $3.2 billion in 2025 to $3.38 billion in 2026, at a compound annual growth rate (CAGR) of 5.7%. The historical increase in this market can be attributed to factors such as the rising prevalence of sleep disorders, heightened stress and lifestyle-related insomnia, extensive use of prescription sleep aids, broadened retail pharmacy access, and increasing awareness of sleep health.
The insomnia therapeutics market is projected to experience substantial expansion over the upcoming years. It is anticipated to reach $4.19 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this growth during the forecast period include the rise of digital sleep therapeutics, a growing preference for non-pharmacological interventions, an expanding aging population, the increasing integration of wearable sleep devices, and the broader availability of telehealth-based insomnia management. Key trends observed within this period encompass the increasing embrace of cognitive behavioral therapy for insomnia, a heightened demand for sleep medications that are not habit-forming, the greater application of orexin receptor antagonists, the development of home-based sleep therapy options, and the enhanced incorporation of sleep tracking into treatment strategies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24255&type=smp
What Influential Factors Are Boosting The Insomnia Therapeutics Market Demand?
Elevated stress levels and evolving lifestyle patterns are projected to drive the expansion of the insomnia therapeutics market in the coming years. These refer to the psychological and behavioral modifications in daily routines and obligations that result in emotional strain and disrupted sleep. The rise in stress and lifestyle changes is largely propelled by constant digital connectivity, which blurs work-life boundaries and curtails time for genuine mental rest. Insomnia therapeutics plays a vital role by offering effective, science-backed treatment solutions designed to restore healthy sleep patterns, reduce sleep-related anxiety, and foster mental well-being amidst modern stressors. For instance, in May 2024, the American Psychiatric Association (APA), a US-based organization of psychiatrists, reported that the percentage of U.S. adults feeling more anxious increased from 32% in 2022 to 37% in 2023, reaching 43% in 2024. This indicates that the rising stress levels and lifestyle changes are significantly contributing to the growth of the insomnia therapeutics market.
How Does Segment Analysis Break Down The Insomnia Therapeutics Market Structure?
The insomnia therapeutics market covered in this report is segmented –
1) By Treatment Type: Drugs, Medical Devices
2) By Formulation: Tablets, Capsules, Liquid Solutions, Patches
3) By Route Of Administration: Oral, Intravenous, Transdermal, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinics, Wellness Centers
Subsegments:
1) By Drugs: Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists, Other Drugs
2) By Medical Devices: Cognitive Behavioral Therapy Devices (CBT-I Devices), Polysomnography Devices, Sleep Tracking Devices, Neurostimulation Devices, Light Therapy Devices
What Trends Are Driving Changes In The Insomnia Therapeutics Market?
Leading companies in the insomnia therapeutics market are prioritizing the development of advanced therapies, such as dual orexin receptor antagonists (DORAs), to offer targeted treatment options with fewer adverse effects and enhanced safety profiles. A DORA is a category of medicine that works by blocking both orexin-1 and orexin-2 receptors in the brain to facilitate sleep by inhibiting the wakefulness signaling pathway, commonly employed in managing insomnia. For instance, in June 2023, Idorsia Pharmaceuticals Ltd., a Switzerland-based pharmaceutical company, launched QUVIVIQ (daridorexant), a first-in-class dual orexin receptor antagonist (DORA) intended for treating chronic insomnia disorder. This therapy is formulated to lessen nighttime wakefulness without disrupting natural sleep architecture, providing patients with improved sleep initiation, duration, and daytime functionality. Its authorization represents a notable progression in insomnia treatment, delivering a precise mechanism of action unlike traditional sedative-hypnotics and addressing the demand for sustained, non-habit-forming therapeutic solutions.
Who Are The Firms Contributing To The Insomnia Therapeutics Market Ecosystem?
Major companies operating in the insomnia therapeutics market are Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Eisai Co. Ltd., Sumitomo Pharma Co. Ltd., Astellas Pharma Inc., Acadia Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Idorsia Ltd., Minerva Neurosciences, Neurim Pharmaceuticals Ltd., Big Health, Cerêve Inc., Innovative Neurological Devices, Neurovalens, Electromedical Products International Inc., Pear Therapeutics, ResMed Inc.
Access The Complete Insomnia Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/report/insomnia-therapeutics-global-market-report
Which Region Is The Dominant Market In The Insomnia Therapeutics Market?
North America was the largest region in the insomnia therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insomnia therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Insomnia Therapeutics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=24255&type=smp
Browse Through More Reports Similar to the Global Insomnia Therapeutics Market 2026, By The Business Research Company
Insomnia Market Report 2026
https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report
Dental Sleep Medicine Market Report 2026
https://www.thebusinessresearchcompany.com/report/dental-sleep-medicine-global-market-report
Sleep Testing Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/sleep-testing-services-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model